Related Experiment Video
Updated: Jul 24, 2026

07:03
Implantation of hiPSC-derived Cardiac-muscle Patches after Myocardial Injury in a Guinea Pig Model
Published on: March 18, 2019
Myopathy in guinea pigs
Journal of the American Veterinary Medical Association
|November 1, 1977
Summary
Nutritional muscular dystrophy in guinea pigs was caused by diet. Changing the feed and supplementing with sodium selenite and alphatocopherol resolved the myopathy, preventing further deaths.
Area of Science:
- Veterinary Pathology
- Animal Nutrition
- Biochemistry
Background:
- Nutritional deficiencies can cause significant health issues in animal colonies.
- Muscular dystrophy in guinea pigs can lead to severe morbidity and mortality.
- Dietary imbalances are a common cause of disease outbreaks in captive animals.
Purpose of the Study:
- To investigate the cause of a myopathy outbreak in a guinea pig colony.
- To identify the clinical and pathological features of the condition.
- To determine effective treatment and preventative measures.
Main Methods:
- Observation of clinical signs and mortality in a guinea pig colony.
- Necropsy and histopathological examination of affected animals.
- Dietary modification and therapeutic intervention with sodium selenite and alphatocopherol.
Main Results:
- A myopathy resembling nutritional muscular dystrophy affected 54 of 150 guinea pigs, with 27 deaths.
- Clinical signs included depression, conjunctivitis, and reluctance to move, with widespread muscle lesions.
- Dietary change and supplementation with sodium selenite and alphatocopherol led to remission of clinical signs.
Conclusions:
- The myopathy was likely caused by a nutritional deficiency in the guinea pig diet.
- Dietary adjustments and supplementation with antioxidants and selenium are effective in treating and preventing this condition.
- This study highlights the importance of balanced nutrition in maintaining animal health in research settings.
Related Concept Videos
Myasthenia Gravis: Overview and Treatment
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
Myasthenia Gravis: Diagnostic Tests
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
Disorders of the Skeletal Muscle
The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Myasthenia Gravis ll: Pathophysiology
The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...

